Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HTLV-1 positive and negative T cells cloned from infected individuals display telomerase and telomere genes deregulation that predominate in activated but untransformed CD4+ T cells.
Zane L, Sibon D, Capraro V, Galia P, Karam M, Delfau-Larue MH, Gilson E, Gessain A, Gout O, Hermine O, Mortreux F, Wattel E. Zane L, et al. Among authors: sibon d. Int J Cancer. 2012 Aug 15;131(4):821-33. doi: 10.1002/ijc.26270. Epub 2012 Apr 18. Int J Cancer. 2012. PMID: 21717459
[A medical-pharmaceutical partnership model as a contributor to the success in conditioning regimen for allogenic hematopoietic stem cell transplantation in adults: a cross-reflection on our organizations].
Bourget P, Falaschi L, Suarez F, Galland V, Blot D, Trompette C, Sibon D, Fontbrune FS, Merlette C, Vidal F, Corriol O, Giraud B, Broissand C, Clement R, Hermine O. Bourget P, et al. Among authors: sibon d. Bull Cancer. 2012 Jun;99(6):643-53. doi: 10.1684/bdc.2012.1589. Bull Cancer. 2012. PMID: 22645281 French.
Early posttransplantation donor-derived invariant natural killer T-cell recovery predicts the occurrence of acute graft-versus-host disease and overall survival.
Rubio MT, Moreira-Teixeira L, Bachy E, Bouillié M, Milpied P, Coman T, Suarez F, Marcais A, Sibon D, Buzyn A, Caillat-Zucman S, Cavazzana-Calvo M, Varet B, Dy M, Hermine O, Leite-de-Moraes M. Rubio MT, et al. Among authors: sibon d. Blood. 2012 Sep 6;120(10):2144-54. doi: 10.1182/blood-2012-01-404673. Epub 2012 Jun 22. Blood. 2012. PMID: 22730537 Free article.
Clinical trials of adult T-cell leukaemia/lymphoma treatment.
Marçais A, Suarez F, Sibon D, Bazarbachi A, Hermine O. Marçais A, et al. Among authors: sibon d. Leuk Res Treatment. 2012;2012:932175. doi: 10.1155/2012/932175. Epub 2012 Feb 14. Leuk Res Treatment. 2012. PMID: 23213552 Free PMC article.
Therapeutic options for adult T-cell leukemia/lymphoma.
Marçais A, Suarez F, Sibon D, Frenzel L, Hermine O, Bazarbachi A. Marçais A, et al. Among authors: sibon d. Curr Oncol Rep. 2013 Oct;15(5):457-64. doi: 10.1007/s11912-013-0332-6. Curr Oncol Rep. 2013. PMID: 23943384 Review.
Serotonin is a key factor for mouse red blood cell survival.
Amireault P, Bayard E, Launay JM, Sibon D, Le Van Kim C, Colin Y, Dy M, Hermine O, Côté F. Amireault P, et al. Among authors: sibon d. PLoS One. 2013 Dec 17;8(12):e83010. doi: 10.1371/journal.pone.0083010. eCollection 2013. PLoS One. 2013. PMID: 24358245 Free PMC article.
86 results